Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolonged GnRh Agonist Therapy in Endometrioma IVF
NCT02737800Completed
- Sponsor
- Kasr Al Ainy Hospital
- Start
- Apr 2016
- Primary completion
- Aug 2017
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of triptorelin in endometrioma (4 arms), sponsored by Kasr Al Ainy Hospital. Primary endpoint: Number of patients with urine pregnancy test positive. Started Apr 2016; status: completed.
02
Drugs
triptorelin
03
Conditions
endometrioma
Beyond the preview
Go deeper on NCT02737800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02737800.